University of Surrey
surrey.ac.ukTotal trials
89
Active
13
Phase 3
3
Total enrollment
11,828
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Healthy7
- Obesity7
- Vitamin D Deficiency5
- Anxiety4
- Cancer3
- Stroke3
- Celiac Disease in Children2
- Varicose Veins2
Frequently asked questions about University of Surrey
- How many clinical trials does University of Surrey have on ClinicalTrials.gov?
- University of Surrey is listed as the lead sponsor on 89 clinical trials in ClinicalTrials.gov, 13 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University of Surrey's trials are in Phase 3?
- 3 of University of Surrey's trials are in Phase 3.
- What therapeutic areas does University of Surrey focus on?
- University of Surrey's most-studied conditions on ClinicalTrials.gov are Healthy, Obesity, Vitamin D Deficiency, Anxiety, Cancer.